Delivery Order SPE2DB24D8002-SPE2DB25FJNAU

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566211938 NURTEC ODT 75 MG TABLET 8S. The delivery order, valued at $11,724.07, is for a firm fixed price contract with an ultimate completion date of October 28, 2024. The contract is not set aside and is part of DLA's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that enables Dakota Drug,...
This is a $5,778.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award is not associated with any larger contract vehicle and does not have a set-aside designation. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the Department of Defense and DLA,...
This firm fixed-price delivery order contract, valued at $14,543.54, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S, which supports the medical supply chain operations of the U.S. Armed Forces. The contract has an ultimate completion date of June 11, 2024 and was awarded on June 10, 2024 without any set-aside...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,506.31 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $6,946.47 contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a prescription pharmaceutical product. The order has an ultimate completion date of June 18, 2024. There is no set-aside designation for this contract. Dakota Drug, Inc. has over two decades of...
The Defense Logistics Agency (DLA) awarded a $6,555.86 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, identified as SPE2DB24D8003, is for the delivery of 4565860418 NURTEC ODT 75 MG TABLET 8S pharmaceutical products. This delivery order is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $11,338.38, is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription pharmaceutical product. This award supports the DLA Troop Support Medical's mission of providing comprehensive medical supply chain operations for the U.S. Armed Forces. The contract has a period of performance...
This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJNAR, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,674.89, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of January 27, 2025. Dakota Drug, Inc. holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Dakota Drug, Inc. The $12,375.92 firm fixed-price delivery order is for the pharmaceutical product Nurtec ODT 75 mg Tablet 8s, with a period of performance through September 17, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged business that provides a wide range of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of...
This is a firm fixed-price delivery order contract (SPE2DX15D8001|SPE2DX24FBQWC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,294.45 contract is for the delivery of Nurtec ODT 75 mg tablets. This contract is not associated with a larger vehicle and does not have a set-aside designation. As a prime contractor to the Department of Defense, Dakota...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJNAU
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of NURTEC ODT 75 MG TABLET 8S. The total ceiling value of the contract is $13,362.48, with a period of performance through January 28, 2025. The contract is not set aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations through the DLA Troop Support Medical's ECAT Generation V Program.

Generated 4/28/25, 9:54 AM